Stay updated on Presendin in IIH Study: Clinical Trial
Sign up to get notified when there's something new on the Presendin in IIH Study: Clinical Trial page.

Latest updates to the Presendin in IIH Study: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for Presendin in idiopathic intracranial hypertension is now displayed, with study design, eligibility criteria, outcome measures, results, and a notice that the trial was terminated and is no longer recruiting.SummaryDifference67%

- Check15 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA notice about NIH terminology changes appears above the page, explaining that some content may use “Super Intelligence” alongside “Artificial Intelligence.”SummaryDifference1%

- Check29 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe ClinicalTrials.gov site revision in the footer changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now renders a 403 Forbidden error instead of the study record content, signaling an access restriction. The surrounding site chrome remains visible, but the study details are not accessible.SummaryDifference19%

Stay in the know with updates to Presendin in IIH Study: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Presendin in IIH Study: Clinical Trial page.